📰 Launch Dynamix News
Page 4 - Launch Dynamix News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Launch Dynamix. Real-time updates on events, politics, business and more.
June 7, 2022
/PRNewswire/ -- According to the latest deep dive report published as part of Spherixs Launch Dynamix™: Rinvoq in Ulcerative Colitis (US) service, AbbVies...
June 2, 2022
/PRNewswire/ -- Glomerulonephritis is a major contributor of end-stage renal disease across the globe, with IgA nephropathy (IgAN), also known as Bergers...
June 2, 2022
/PRNewswire/ -- Glomerulonephritis is a major contributor of end-stage renal disease across the globe, with IgA nephropathy (IgAN), also known as Bergers...
March 3, 2022
/PRNewswire/ -- Spherix Global Insights, an independent market intelligence firm, recently collected feedback from 103 US ophthalmologists on the neovascular...
March 3, 2022
/PRNewswire/ -- Spherix Global Insights, an independent market intelligence firm, recently collected feedback from 103 US ophthalmologists on the neovascular...
February 14, 2022
/PRNewswire/ -- At the end of last year, argenxs Vyvgart (efgartigimod alfa-fcab) was approved by the FDA for the treatment of generalized myasthenia gravis...
January 13, 2022
/PRNewswire/ -- Impels new entrant into the acute migraine landscape, the dihydroergotamine mesylate (DHE) nasal spray, Trudhesa, is off to a somewhat light...
January 13, 2022
/PRNewswire/ -- Impels new entrant into the acute migraine landscape, the dihydroergotamine mesylate (DHE) nasal spray, Trudhesa, is off to a somewhat light...
December 1, 2021
/PRNewswire/ -- For those of us following the evolution of neurology pharmaceutical markets, 2021 will be remembered by many for the tumultuous roll out of...
December 1, 2021
/PRNewswire/ -- For those of us following the evolution of neurology pharmaceutical markets, 2021 will be remembered by many for the tumultuous roll out of...